Literature DB >> 25376370

Roles of glucose transporter-1 and the phosphatidylinositol 3‑kinase/protein kinase B pathway in cancer radioresistance (review).

Jin Fang1, Shui-Hong Zhou2, Jun Fan3, Sen-Xiang Yan4.   

Abstract

The mechanisms underlying cancer radioresistance remain unclear. Several studies have found that increased glucose transporter‑1 (GLUT‑1) expression is associated with radioresistance. Recently, the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) pathway was reported to be involved in the control of GLUT‑1 trafficking and activity. Activation of the PI3K/Akt pathway may itself be associated with cancer radioresistance. Thus, increasing attention has been devoted to the effects of modifying the expression of GLUT‑1 and the PI3K/Akt pathway on the increase in the radiosensitivity of cancer cells. This review discusses the importance of the association between elevated expression of GLUT‑1 and activation of the PI3K/Akt pathway in the development of radioresistance in cancer.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25376370     DOI: 10.3892/mmr.2014.2888

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  12 in total

1.  Molecular Composition of Serum Exosomes Could Discriminate Rectal Cancer Patients with Different Responses to Neoadjuvant Radiotherapy.

Authors:  Urszula Strybel; Lukasz Marczak; Marcin Zeman; Krzysztof Polanski; Łukasz Mielańczyk; Olesya Klymenko; Anna Samelak-Czajka; Paulina Jackowiak; Mateusz Smolarz; Mykola Chekan; Ewa Zembala-Nożyńska; Piotr Widlak; Monika Pietrowska; Anna Wojakowska
Journal:  Cancers (Basel)       Date:  2022-02-16       Impact factor: 6.639

Review 2.  Clinically relevant radioresistant cell line: a simple model to understand cancer radioresistance.

Authors:  Yoshikazu Kuwahara; Mehryar Habibi Roudkenar; Yusuke Urushihara; Yohei Saito; Kazuo Tomita; Amaneh Mohammadi Roushandeh; Tomoaki Sato; Akihiro Kurimasa; Manabu Fukumoto
Journal:  Med Mol Morphol       Date:  2017-10-24       Impact factor: 2.309

3.  In vivo evaluation of the effects of simultaneous inhibition of GLUT-1 and HIF-1α by antisense oligodeoxynucleotides on the radiosensitivity of laryngeal carcinoma using micro 18F-FDG PET/CT.

Authors:  Li-Fang Shen; Xin Zhao; Shui-Hong Zhou; Zhong-Jie Lu; Kui Zhao; Jun Fan; Min-Li Zhou
Journal:  Oncotarget       Date:  2017-05-23

Review 4.  Role of metabolism in cancer cell radioresistance and radiosensitization methods.

Authors:  Le Tang; Fang Wei; Yingfen Wu; Yi He; Lei Shi; Fang Xiong; Zhaojian Gong; Can Guo; Xiayu Li; Hao Deng; Ke Cao; Ming Zhou; Bo Xiang; Xiaoling Li; Yong Li; Guiyuan Li; Wei Xiong; Zhaoyang Zeng
Journal:  J Exp Clin Cancer Res       Date:  2018-04-23

5.  Impact of Hypoxia on Carbon Ion Therapy in Glioblastoma Cells: Modulation by LET and Hypoxia-Dependent Genes.

Authors:  Samuel Valable; Aurélie N Gérault; Gaëlle Lambert; Marine M Leblond; Clément Anfray; Jérôme Toutain; Karim Bordji; Edwige Petit; Myriam Bernaudin; Elodie A Pérès
Journal:  Cancers (Basel)       Date:  2020-07-23       Impact factor: 6.639

6.  GLUT-1 siRNA Enhances Radiosensitization Of Laryngeal Cancer Stem Cells Via Enhanced DNA Damage, Cell Cycle Redistribution, And Promotion Of Apoptosis In Vitro And In Vivo.

Authors:  Jiang-Tao Zhong; Qi Yu; Shui-Hong Zhou; Er Yu; Yang-Yang Bao; Zhong-Jie Lu; Jun Fan
Journal:  Onco Targets Ther       Date:  2019-11-05       Impact factor: 4.147

7.  CCL5 activation of CCR5 regulates cell metabolism to enhance proliferation of breast cancer cells.

Authors:  Darrin Gao; Ramtin Rahbar; Eleanor N Fish
Journal:  Open Biol       Date:  2016-06       Impact factor: 6.411

Review 8.  Warburg effect, hexokinase-II, and radioresistance of laryngeal carcinoma.

Authors:  Jiang-Tao Zhong; Shui-Hong Zhou
Journal:  Oncotarget       Date:  2017-02-21

Review 9.  A New Twist in Protein Kinase B/Akt Signaling: Role of Altered Cancer Cell Metabolism in Akt-Mediated Therapy Resistance.

Authors:  Isabell Götting; Verena Jendrossek; Johann Matschke
Journal:  Int J Mol Sci       Date:  2020-11-13       Impact factor: 5.923

10.  Progress in Natural Compounds/siRNA Co-delivery Employing Nanovehicles for Cancer Therapy.

Authors:  Milad Ashrafizadeh; Ali Zarrabi; Kiavash Hushmandi; Farid Hashemi; Ebrahim Rahmani Moghadam; Mehdi Raei; Mahshad Kalantari; Shima Tavakol; Reza Mohammadinejad; Masoud Najafi; Franklin R Tay; Pooyan Makvandi
Journal:  ACS Comb Sci       Date:  2020-10-23       Impact factor: 3.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.